Stockscreener 앱 받기
5.40
3.45%
0.18
전일 마감가:
$5.22
열려 있는:
$5.32
하루 거래량:
441.95K
Relative Volume:
1.21
시가총액:
$208.34M
수익:
-
순이익/손실:
$-42.05M
주가수익비율:
-1.9149
EPS:
-2.82
순현금흐름:
$-35.26M
1주 성능:
+10.88%
1개월 성능:
+71.97%
6개월 성능:
+38.11%
1년 성능:
+221.43%
1일 변동 폭
$5.2301
$5.45
1주일 범위
$4.81
$5.879
52주 변동 폭
$1.68
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
명칭
Protara Therapeutics Inc
전화
646-844-0337
주소
345 PARK AVENUE SOUTH, NEW YORK, NY
TARA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
5.40 | 201.40M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.45 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.07 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-16 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-07-10 | 재개 | Guggenheim | Buy |
| 2021-06-04 | 개시 | H.C. Wainwright | Buy |
| 2021-02-17 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-07-29 | 개시 | Guggenheim | Buy |
모두보기
Protara Therapeutics Inc 주식(TARA)의 최신 뉴스
Measuring Protara Therapeutics Inc.’s beta against major indicesJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
How to forecast Protara Therapeutics Inc. trends using time seriesJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Is Protara Therapeutics Inc. stock a safe haven asset2025 Retail Activity & High Yield Stock Recommendations - newser.com
How Protara Therapeutics Inc. (1KPA) stock reacts to fiscal policiesQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Trend analysis for Protara Therapeutics Inc. this weekSell Signal & AI Based Trade Execution Alerts - newser.com
Will Protara Therapeutics Inc. stock benefit from upcoming earnings reportsPortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
Will Protara Therapeutics Inc. stock attract more institutional investorsMarket Performance Summary & Weekly Setup with High ROI Potential - newser.com
How institutional ownership impacts Protara Therapeutics Inc. stock2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Exit strategy if you’re trapped in Protara Therapeutics Inc.Bond Market & Capital Efficiency Focused Ideas - newser.com
Will Protara Therapeutics Inc. bounce back from current supportJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com
Can a trend reversal in Protara Therapeutics Inc. lead to recoveryMarket Activity Summary & Real-Time Sentiment Analysis - newser.com
What is the fair value estimate for Protara Therapeutics Inc. (1KPA) stock in 2025Quarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Custom watchlist performance reports with Protara Therapeutics Inc.July 2025 Action & Technical Pattern Based Buy Signals - newser.com
Why hedge funds are buying Protara Therapeutics Inc. stockShare Buyback & Verified Momentum Stock Watchlist - newser.com
Protara Therapeutics' (TARA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Key resistance and support levels for Protara Therapeutics Inc.2025 Price Action Summary & Verified Technical Signals - newser.com
Advanced analytics toolkit walkthrough for Protara Therapeutics Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
Is Protara Therapeutics Inc. stock a contrarian buyProfit Target & Trade Opportunity Analysis - newser.com
Is Protara Therapeutics Inc. showing signs of accumulationWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - newser.com
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Will Protara Therapeutics Inc. stock sustain high P E ratiosSwing Trade & Long-Term Safe Investment Ideas - newser.com
Will Protara Therapeutics Inc. (1KPA) stock see valuation expansion2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Biotech Firm Protara Therapeutics Issues $4.41 Stock Options and RSUs in Key Employee Grant - Stock Titan
JonesTrading Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Is Protara Therapeutics Inc. forming a reversal pattern2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
Protara Therapeutics Inc (TARA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Protara Therapeutics Inc 주식 (TARA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zummo Jacqueline | Chf Scientific Operations Off |
Mar 26 '25 |
Sale |
4.53 |
21,224 |
96,145 |
98,861 |
1.12%
자본화:
|
볼륨(24시간):